Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 3:41 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Chione Ltd | 4,400,000 3.9% | -600,000 (-12.00%) | View |
| 2022-11-28 3:59 pm Purchase | 13G | ACRIVON THERAPEUTICS INC ACRV | Chione Ltd | 3,856,597 18.5% | 3,856,597 (New Position) | View |
| 2022-02-11 2:54 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Chione Ltd | 5,000,000 6.6% | -500,000 (-9.09%) | View |
| 2021-07-26 5:19 pm Purchase | 13D | SERA PROGNOSTICS INC SERA | Chione Ltd | 1,980,350 6.8% | 1,980,350 (New Position) | View |
| 2021-02-16 4:03 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Chione Ltd | 5,500,000 7.5% | -195,499 (-3.43%) | View |
| 2020-02-14 3:31 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Chione Ltd | 5,695,499 9.1% | -1,935,768 (-25.37%) | View |